Financial Results for the quarter and nine months ended December 31, 2025.

Net loss reportedRevenue declinedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.1%Reaction day

₹37.55

prior close

₹35.77

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.8%-5.9% vs market

Breweries & Distilleries peers, median of 24sector+1.8%-5.9% vs sector

On the reaction day the stock moved 5.9 pts less than Nifty Microcap 250 and 5.9 pts less than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.4

10m

+5.3

15m

+2.3

30m

+4.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.1+1.8-5.9+1.8-5.9

Next day

+0.9+0.5+0.3+0.2+0.7

+5.9+4.3+1.6+2.6+3.2

+6.8+5.6+1.2+4.6+2.2

+4.0+4.6-0.6+3.7+0.4

+8.8+3.8+5.0+3.4+5.3

+3.9+7.5-3.7+4.8-0.9

15d

-8.2+3.8-12.0+3.9-12.1

-19.2-0.3-18.9-1.4-17.8

-48.5-9.6-38.9-10.2-38.3

-11.3+9.9-21.3+3.8-15.1

UpDownMarket · Nifty Microcap 250Sector · Breweries & Distilleries peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board approved unaudited standalone and consolidated financial results for Q3 FY26 (Oct–Dec 2025) and 9M FY26 (Apr–Dec 2025), along with H1 results. Standalone Q3 FY26 showed zero revenue from operations, total expenses of Rs. 15.04 lakhs, and a loss after tax of Rs. 15.04 lakhs (EPS: -0.03). Standalone 9M FY26 revenue from operations was a modest Rs. 25.88 lakhs, and after adding other income of Rs. 30.80 lakhs, the company posted a small profit of Rs. 20.21 lakhs — mostly from non-operating income, while core operations remained loss-making. The company noted it is in a scale-up phase, recently re-listed (Dec 2024), with new shares listed in May 2025, and is building bottling capacity and state excise licenses. The Board also authorised the MD to evaluate acquisitions and enter into marketing/distribution arrangements.

Likely market impact

Near-term the results are disappointing: no operating revenue in Q3 and continued operating losses suggest the planned scale-up has not yet translated into meaningful sales, which is negative for sentiment. However, the 9M standalone PBT turned positive on paper and the recent share issuances and acquisitions have substantially expanded the balance sheet, so any successful execution of the licensing and bottling plan in coming quarters could be a catalyst.